syphilis%20-%20primary
SYPHILIS - PRIMARY
Syphilis is a vertically or sexually transmitted infection caused by Treponema pallidum subspecies pallidum.
In the primary stage of acquired syphilis, there is an appearance of a painless ulcer (chancre). Then in the secondary stage, there are skin rashes and sores on mucous membranes.
In the latent stage, it is asymptomatic and not communicable. It is in the tertiary or late stage that it is symptomatic but not communicable; it usually appears 10-20 years after 1st infection.

Principles of Therapy

  • A treponemocidal level of antimicrobials needs to be achieved in the serum to provide effective treatment for primary syphilis
  • Follow recommendations for treatment of late syphilis if the stage of syphilis is unknown
  • Duration of treponemocidal level of antibiotic should be at least 7-10 days

Pharmacotherapy

Antibiotic Therapy

Penicillin

  • Eg Benzathine, aqueous procaine, aqueous crystalline penicillin, Amoxicillin
  • Preferred drug for the treatment of all stages of syphilis
    • Parenteral penicillin G is the only therapy with documented efficacy for syphilis during pregnancy
  • Adequate penicillin therapy ends infectivity within 24-48 hours
  • Parenteral route is preferred because it provides guaranteed bioavailability and supervised treatment
    • Oral penicillin preparations are not appropriate for the treatment of syphilis
  • Replacing half of the solvent by Lidocaine 1% solution may reduce injection-associated pain
  • Efficacy of penicillin is well established based on clinical experience, case series and clinical trials

Alternatives to Penicillin

  • May be used for the treatment of primary syphilis in patients who are non-pregnant, penicillin-allergic and inpatients who refuse parenteral treatment
  • Data to support the use of alternatives to penicillin in the treatment of early syphilis are limited; hence, patient streated with alternative agents to penicillin should be followed closely because efficacy of these regimens is not well documented

Tetracycline Derivatives

  • Eg Doxycycline, Tetracycline
  • Doxycycline can be given as an alternative to Penicillin in both early and late syphilis  
    • Avoid Doxycycline in pregnant women

Cephalosporin

  • Ceftriaxone
    • Penetrates blood-brain barrier well

Macrolides

  • May be considered if there is no other suitable treatment option and close follow-up can be done
  • Azithromycin  
    • Intrinsically resistant T pallidum strains have been detected
    • Also effective against C trachomatis, N gonorrhoeae and H ducreyi
  • Erythromycin
    • Least effective and does not penetrate blood-brain and placental barrier
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Aug 2017
New drug applications approved by US FDA as of 1 - 15 June 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
16 Mar 2017
Probiotics have a long history of use in humans. Defined as "live organisms that confer a health benefit on the host when administered in adequate amounts", the spectrum of use of probiotics in humans ranges from foods and dietary supplements to pharmaceutical/nutraceutical products to affect general health and disease. While the genera Lactobacillus and Bifidobacterium are the two most common probiotics associated with consumer products, there exist other organisms (eg, the yeast Saccharomyces cerevisiae, some non-pathogenic strains of Escherichia coli and Bacillus species) that are used as probiotics.1–3 One of them is the probiotic strain B. clausii that has been found to be effective for the treatment of diarrhoea and antibiotic-associated gastrointestinal side effects.4–6
Stephen Padilla, 06 Dec 2016
Dengvaxia, a recombinant, live-attenuated dengue vaccine, has the potential to bring down the number of hospitalizations by 13 to 25 percent and be cost-effective in areas of moderate-to-high dengue endemicity, according to a model comparison study.
06 Nov 2017
Treatment with rifaximin appears to effectively prevent spontaneous bacterial peritonitis in patients with cirrhosis and ascites compared with systemically absorbed antibiotics and placebo, a study has found.